Randomized Controlled Trial
Copyright ©The Author(s) 2020.
World J Hepatol. Nov 27, 2020; 12(11): 1098-1114
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1098
Table 5 Relative changes between baseline and postoperative values in the two groups
Change, %
AT III
P (95%CI)
PC
P (95%CI)
INR
P (95%CI)
Day 1a(4.6 to 15.4)a(2.2 to 13.5)a(-22.6 to -7.5)
Desflurane-17.9 ± 16.7-11.9 ± 13.212.5 ± 17.1
Control-27.9 ± 14.9-20.9 ± 16.127.5 ± 13.6
Day 2a(5.3 to 18.5)b(9.7 to 18.1)b(-39.5 to -11.7)
Desflurane-15.4 ± 16.6-8.2 ± 10.114.5 ± 20.1
Control-27.3 ± 18.9-22.1 ± 16.540.1 ± 31.1
Day 3b(14.3 to 23.7)b(10.2 to 18.9)a(-27.6 to -4.2)
Desflurane-12.1 ± 16.6-8.3 ± 11.917.9 ± 15.6
Control-31.1 ± 28.2-22.9 ± 15.733.6 ± 28.2
Day 4a(10.9 to 18.2)a(5.6 to 15.5)a(-26.8 to -4.1)
Desflurane-12.3 ± 19.8-1.4 ± 14.814.4 ± 20.1
Control-23.7 ± 16.2-11.9 ± 15.429.8 ±23.6
Day 5b(9.8 to 22.7)a(2.5 to 14.3)a(-23.7 to -2.2)
Desflurane-3.8 ± 17.73.3 ± 13.67.7 ± 18.7
Control-12.4 ± 17.4-5.5 ±11.522.2 ± 17.8